• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.44% Nasdaq Down 0.42%

    More On BLRX

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    BioLineRx, Ltd. (BLRX)

    -NasdaqCM
    2.06 Down 0.05(2.37%) Apr 1, 4:00PM EDT
    Add to Portfolio
    Prev Close:2.11
    Open:2.07
    Bid:2.00 x 500
    Ask:N/A
    1y Target Est:9.25
    Beta:1.79
    Next Earnings Date:N/A
    Day's Range:2.01 - 2.12
    52wk Range:1.20 - 3.28
    Volume:501,778
    Avg Vol (3m):737,464
    Market Cap:70.28M
    P/E (ttm):N/A
    EPS (ttm):-0.31
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):8.58
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.03
    Quarterly EPS Est (Mar-15) :-0.04
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioLineRx Ltd., a clinical stage biopharmaceutical development company, engages in identifying, in-licensing, and developing therapeutic candidates that address unmet medical needs. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback